Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leucin-rich alpha2 Glycoprotein (LRG): A Novel Acute Phase Protein Related With Stage 3 Periodontitis

NCT04383561 is registered in ClinicalTrials.gov with Aydin Adnan Menderes University as lead sponsor.

NCT NCT04383561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04383561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leucin-rich alpha2 Glycoprotein (LRG): A Novel Acute Phase Protein Related With Stage 3 Periodontitis
Lead sponsor
Aydin Adnan Menderes University
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2019
Completion date
February 15, 2020
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute-phase response, inflammation, periodontitis